215 related articles for article (PubMed ID: 7010257)
1. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy in advanced gastrointestinal malignancy.
Vaughn CB; Brady P; Chinn BJ; Daversa GC; Parzuchowski JS
Oncology; 1980; 37(1):57-61. PubMed ID: 6985729
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer.
Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R
Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974
[TBL] [Abstract][Full Text] [Related]
4. Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas.
Vaughn C; Chapman J; Chinn B; Ward D; Groshko G; Maniscalco B; Reznik S; Piper D
Am J Clin Oncol; 1989 Feb; 12(1):49-52. PubMed ID: 2492142
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
Krauss S; Sonoda T; Solomon A
Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
[No Abstract] [Full Text] [Related]
6. MItomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma.
Bonomi PD; Chandra G; Rossof AH; Klaassen D
Cancer Chemother Pharmacol; 1980; 5(1):39-42. PubMed ID: 7006846
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of advanced gastrointestinal cancer.
Moertel CG
Cancer; 1975 Aug; 36(2):675-82. PubMed ID: 168961
[TBL] [Abstract][Full Text] [Related]
9. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
Kessinger MA; Foley JF; Lemon HM
Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
[TBL] [Abstract][Full Text] [Related]
11. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Douglass HO; Lavin PT; Moertel CG
Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
Moertel CG
JAMA; 1976 May; 235(19):2135-6. PubMed ID: 946546
[No Abstract] [Full Text] [Related]
13. Therapy of advanced colorectal carcinoma with 5-fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate.
White DR; Richards F; Muss HB; Cooper MR; Spurr CL
Cancer; 1980 Feb; 45(4):662-5. PubMed ID: 6986968
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of gastrointestinal cancer.
Moertel CG
N Engl J Med; 1978 Nov; 299(19):1049-52. PubMed ID: 360064
[No Abstract] [Full Text] [Related]
15. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study.
Gagliano RG; Panettiere FJ; Haas CD; Baker L; Hewlett J; Stuckey WJ; O'Bryan RM; Bottomley R; Heilburn LK
Cancer Clin Trials; 1981; 4(4):401-5. PubMed ID: 7318121
[TBL] [Abstract][Full Text] [Related]
17. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
Trux F
Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
[No Abstract] [Full Text] [Related]
18. [Gastrointestinal tumors: chemotherapeutic preparations].
Queisser W; Heim ME
Fortschr Med; 1983 Apr; 101(13):583-6. PubMed ID: 6852723
[TBL] [Abstract][Full Text] [Related]
19. A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
Smith BJ; Ashford RF; Bakowski M; Hellman K; Newton K; Phillips R; Lambert J; Jones R; Peters N; Evans M
Am J Clin Oncol; 1983 Aug; 6(4):481-4. PubMed ID: 6346856
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones".
Moertel CG; Engstrom P; Lavin PT; Gelber RD; Carbone PP
Surgery; 1979 May; 85(5):509-13. PubMed ID: 155322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
